IS4351A - Nýtt kristallað form af vatnslausri 7-([1a, 5a, 6a]-6-amínó-3-azabísýkló[3.1.0]hex-3-ýl)-6-flúoró-1-(2,4-díflúorófenýl)-1,4-díhýdró-4-oxó-1,8-naftýridín-3-karboxýlsýru, metansúlfonsýrusalt og notkun og aðferð við framleiðslu þeirra - Google Patents

Nýtt kristallað form af vatnslausri 7-([1a, 5a, 6a]-6-amínó-3-azabísýkló[3.1.0]hex-3-ýl)-6-flúoró-1-(2,4-díflúorófenýl)-1,4-díhýdró-4-oxó-1,8-naftýridín-3-karboxýlsýru, metansúlfonsýrusalt og notkun og aðferð við framleiðslu þeirra

Info

Publication number
IS4351A
IS4351A IS4351A IS4351A IS4351A IS 4351 A IS4351 A IS 4351A IS 4351 A IS4351 A IS 4351A IS 4351 A IS4351 A IS 4351A IS 4351 A IS4351 A IS 4351A
Authority
IS
Iceland
Prior art keywords
naphthyridine
azabicyclo
difluorophenyl
hex
dihydro
Prior art date
Application number
IS4351A
Other languages
English (en)
Inventor
A. Handanyan Lynne
L. Hendrickson Robert
J. Johnson Phillip
A. Morris Thomas
Norris Timothy
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of IS4351A publication Critical patent/IS4351A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IS4351A 1995-06-06 1996-06-03 Nýtt kristallað form af vatnslausri 7-([1a, 5a, 6a]-6-amínó-3-azabísýkló[3.1.0]hex-3-ýl)-6-flúoró-1-(2,4-díflúorófenýl)-1,4-díhýdró-4-oxó-1,8-naftýridín-3-karboxýlsýru, metansúlfonsýrusalt og notkun og aðferð við framleiðslu þeirra IS4351A (is)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1995/007211 WO1996039406A1 (en) 1995-06-06 1995-06-06 NOVEL CRYSTAL FORM OF ANHYDROUS 7-([1α, 5α, 6α]-6-AMINO-3-AZABICYCLO[3.1.0]HEX-3-YL)-6-FLUORO-1-(2,4-DIFLUOROPHENYL)-1,4-DIHYDRO-4-OXO-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID, METHANESULFONIC ACID SALT

Publications (1)

Publication Number Publication Date
IS4351A true IS4351A (is) 1996-12-07

Family

ID=39431076

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4351A IS4351A (is) 1995-06-06 1996-06-03 Nýtt kristallað form af vatnslausri 7-([1a, 5a, 6a]-6-amínó-3-azabísýkló[3.1.0]hex-3-ýl)-6-flúoró-1-(2,4-díflúorófenýl)-1,4-díhýdró-4-oxó-1,8-naftýridín-3-karboxýlsýru, metansúlfonsýrusalt og notkun og aðferð við framleiðslu þeirra

Country Status (38)

Country Link
US (1) US5763454A (is)
EP (1) EP0789697B1 (is)
JP (1) JP3145715B2 (is)
KR (1) KR100191989B1 (is)
CN (1) CN1055474C (is)
AR (1) AR002753A1 (is)
AU (1) AU703634B2 (is)
BG (1) BG62443B1 (is)
BR (1) BR9602630A (is)
CA (1) CA2223404C (is)
CZ (1) CZ285878B6 (is)
DE (1) DE69503066T2 (is)
DK (1) DK0789697T3 (is)
DZ (1) DZ2046A1 (is)
ES (1) ES2117426T3 (is)
FI (1) FI974441A0 (is)
HR (1) HRP960267B1 (is)
HU (1) HUP9601540A3 (is)
IL (1) IL118488A (is)
IS (1) IS4351A (is)
LV (1) LV11619B (is)
MA (1) MA23892A1 (is)
NO (1) NO305599B1 (is)
NZ (1) NZ286735A (is)
OA (1) OA10293A (is)
PE (1) PE38097A1 (is)
PL (1) PL314604A1 (is)
RU (1) RU2125571C1 (is)
SG (1) SG54339A1 (is)
SI (1) SI9600185A (is)
SK (1) SK280535B6 (is)
TN (1) TNSN96084A1 (is)
TW (2) TW580389B (is)
UA (1) UA44718C2 (is)
UY (1) UY25459A1 (is)
WO (1) WO1996039406A1 (is)
YU (1) YU34596A (is)
ZA (1) ZA964647B (is)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA24500A1 (fr) 1997-03-21 1998-10-01 Lg Life Sciences Ltd Derive du sel d'acide carboxylique de naphthyridine .
US20020032216A1 (en) 1997-03-21 2002-03-14 Lg Chemical Ltd. Salt of naphthyridine carboxylic acid derivative
HN1998000106A (es) 1997-08-01 1999-01-08 Pfizer Prod Inc Composiciones parenterales de alatroflaxacino
DE19800214A1 (de) * 1998-01-06 1999-07-15 Knoll Ag Verfahren zur Herstellung von Doxazosin-Mcsylat in einer als Form A bezeichneten Kristallmodifikation und ein Zwischenprodukt dafür
US7019142B2 (en) * 1998-01-16 2006-03-28 Pfizer Inc. Process for preparing naphthyridones and intermediates
GB9818258D0 (en) * 1998-08-21 1998-10-14 Pfizer Ltd Antifungal compositions
HN1999000141A (es) * 1998-09-03 2000-06-19 Pfizer Prod Inc Procedimiento para preparar sales de trovafloxacina de adicion de acidos.
GB9820405D0 (en) * 1998-09-18 1998-11-11 Smithkline Beecham Plc Process
ES2164520B1 (es) 1999-03-16 2003-04-01 Medichem Sa "procedimiento de obtencion del polimorfo a del mesilato de doxazosina"
US6239141B1 (en) 1999-06-04 2001-05-29 Pfizer Inc. Trovafloxacin oral suspensions
GB9920917D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel process
GB9920919D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel compound
US6657061B2 (en) 2001-06-29 2003-12-02 Grayson Walker Stowell Polymorphic forms of 6-[4-1(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6660864B2 (en) 2001-06-29 2003-12-09 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6388080B1 (en) 2001-06-29 2002-05-14 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6531603B1 (en) 2001-06-29 2003-03-11 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6596871B2 (en) 2001-06-29 2003-07-22 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1h-tetraol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6573382B2 (en) 2001-06-29 2003-06-03 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
KR100517638B1 (ko) 2002-04-08 2005-09-28 주식회사 엘지생명과학 게미플록사신 산염의 새로운 제조방법
CN102512364A (zh) * 2011-12-30 2012-06-27 天津市嵩锐医药科技有限公司 一种供注射用的甲磺酸阿拉曲伐沙星药物组合物
TWI608970B (zh) * 2013-01-11 2017-12-21 參天製藥股份有限公司 內塞和具備該內塞的液體收容容器、以及注口的前端構造和具備該構造的液體收容容器

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
PL166381B1 (pl) * 1989-08-16 1995-05-31 Pfizer Sposób wytwarzania nowych podstawionych kwasów 7-azabicyklochinolonokarboksylowych PL PL PL PL
KR100221386B1 (ko) * 1994-01-18 1999-09-15 디. 제이. 우드, 스피겔 알렌 제이 나프티리돈카복실산 염의 제조방법 및 중간체
GB2289674A (en) * 1994-05-23 1995-11-29 Pfizer Antibacterial naphthyridine

Also Published As

Publication number Publication date
MA23892A1 (fr) 1996-12-31
HU9601540D0 (en) 1996-07-29
UA44718C2 (uk) 2002-03-15
DE69503066T2 (de) 1998-10-15
ZA964647B (en) 1997-10-22
MX9709873A (es) 1998-03-31
DE69503066D1 (de) 1998-07-23
LV11619B (en) 1997-04-20
HUP9601540A2 (en) 1997-02-28
NZ286735A (en) 1998-01-26
SK280535B6 (sk) 2000-03-13
ES2117426T3 (es) 1998-08-01
UY25459A1 (es) 1999-11-17
RU2125571C1 (ru) 1999-01-27
WO1996039406A1 (en) 1996-12-12
FI974441A (fi) 1997-12-05
CN1055474C (zh) 2000-08-16
SG54339A1 (en) 1998-11-16
NO305599B1 (no) 1999-06-28
HRP960267B1 (en) 2000-06-30
IL118488A0 (en) 1996-09-12
HUP9601540A3 (en) 1997-05-28
CN1148596A (zh) 1997-04-30
CA2223404A1 (en) 1996-12-12
AU703634B2 (en) 1999-03-25
BR9602630A (pt) 1998-09-08
AR002753A1 (es) 1998-04-29
BG62443B1 (bg) 1999-11-30
PL314604A1 (en) 1996-12-09
HRP960267A2 (en) 1997-08-31
SK71996A3 (en) 1997-03-05
AU5474996A (en) 1996-12-19
KR970001352A (ko) 1997-01-24
PE38097A1 (es) 1997-10-10
JP3145715B2 (ja) 2001-03-12
US5763454A (en) 1998-06-09
TNSN96084A1 (fr) 2005-03-15
DK0789697T3 (da) 1998-10-19
KR100191989B1 (ko) 1999-06-15
JPH10506650A (ja) 1998-06-30
FI974441A0 (fi) 1997-12-05
CA2223404C (en) 2001-01-16
OA10293A (en) 1997-09-19
TW580389B (en) 2004-03-21
TW403751B (en) 2000-09-01
CZ162596A3 (cs) 1998-09-16
NO962321D0 (no) 1996-06-05
BG100639A (bg) 1997-02-28
SI9600185A (en) 1997-04-30
LV11619A (lv) 1996-12-20
DZ2046A1 (fr) 2002-10-22
YU34596A (sh) 1999-03-04
EP0789697A1 (en) 1997-08-20
NO962321L (no) 1996-12-09
CZ285878B6 (cs) 1999-11-17
EP0789697B1 (en) 1998-06-17
IL118488A (en) 1999-01-26

Similar Documents

Publication Publication Date Title
IS4351A (is) Nýtt kristallað form af vatnslausri 7-([1a, 5a, 6a]-6-amínó-3-azabísýkló[3.1.0]hex-3-ýl)-6-flúoró-1-(2,4-díflúorófenýl)-1,4-díhýdró-4-oxó-1,8-naftýridín-3-karboxýlsýru, metansúlfonsýrusalt og notkun og aðferð við framleiðslu þeirra
NO175530C (no) Fremgangsmåte for fremstilling av 1H-imidazo(4,5-c)- kinoliner, og mellomprodukter derfor
FI883807A0 (fi) Menetelmä farmakologisesti aktiivisten 7-(3-substituoitu-1-pyrrolidinyyli)-1-syklopropyyli-1,4-dihydro-4-okso-1,8-naftyridiini-3-karboksyylihappojohdannaisten valmistamiseksi
FR2624699B1 (fr) Derives heterocycliques de n-carbamoyl-, n-thiocarbamoyl- ou n-amidino-glycine ou beta-alanine utiles comme agents edulcorants
FI913510A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten, raseemisten tai optisesti aktiivisten pyrido/1,2-a/pyratsiinien valmistamiseksi
ITTO920676A0 (it) Procedimento per la produzione di poli acido lattico
ATE242242T1 (de) Derivate von imidazo(1,2-a)pyridin zur behandlung von gastrointestinalen krankheiten
NO170330C (no) Fremgangsmaate for fremstilling av vesentlig optisk rent monohydrat av s-(-)-propyl-2',6'-pipekoloksylididhydroklorid
HUP9903584A3 (en) Salts of quinoline derivatives as nk3 antagonists
NO962545L (no) Krystallinske N-acetyl-neuraminsyrederivater og fremgangsmåter for fremstilling derav
DE69320668D1 (de) Verfahren zur Herstellung von Imidazo(4,5-b)Pyridinderivaten
EP0352005A3 (en) Antiulcer (alkyldithio) quinoline derivatives
DK1073673T3 (da) Hidtil ukendte octahydro-6, 10-dioxo-6H-pyridazino [1,2-a] [1,2] - diazepin-1-carboxylsyre-derivater, fremgangsmåde til deres fremstilling og deres anvendelse til fremstilling af terapeutisk aktive forbindelser
ATE167478T1 (de) Kristallform von wasserfreien 7-((1a,5a,6a)-6- amino-3-azabicyclo (3.1.0.) hex-3-yl)-6-fluoro-1- (2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8- naphthyridin-carbonsäure methanesulfonsäure salz
AP9600851A0 (en) Novel crystal form of anhydrous 7-(1A,5A,6A) -6- amino-3- azabicyclo(3.1.0)hex-3-YL) -6- fluoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo1,8-naphthyridine S-3-carboxylic acid methanesulfonic acid salt
NO308471B1 (no) FremgangsmÕter for fremstilling av lorakarbefmonohydrat og krystallinsk anhydratform av lorakarbef
IS3782A7 (is) Aðferð við framleiðslu nýrra heteróhringtengdra efnasambanda, sem eru mótlyf örvandi amínósýrunema
KR950700295A (ko) 키랄 에틸(5-아미노-1,2-디히드로-2-메틸-3-페닐피리도[3,4-b]피라진-7-일)카르바메이트의 제조방법(Process for Preparing Chiral Ethyl(5-Amino-1,2-Dihydro-2-Methyl-3-Phenylpyrido[3,4-b]Pyrazin-7-yl(Carbamate)
PT82243B (fr) Procede de preparation de nouvelles 5-h pyrido<3',4':4,5>pyrrolo<3,2-c>pyridines
SI1107749T1 (en) Fumaric acid derivatives for the treatment of transplant rejection
NO991098D0 (no) FremgangsmÕte for fremstilling av 2-fenyl-3-naftylpropionsyrederivater
PL287478A1 (en) Method of obtaining novel derivatives of 6-h-indolo-(2,3-b) quinoline
PL287479A1 (en) Method of obtaining novel derivatives of 5,6-dimethyl-6-h-indolo (2,3-b) quinoline
ZA886872B (en) Substituted pyridines as dopamine-beta-hydroxylaseocular hypotensive agents inhibitors